U.S. flag

An official website of the United States government

NM_000251.3(MSH2):c.1760G>C (p.Gly587Ala) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 23, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002401664.2

Allele description [Variation Report for NM_000251.3(MSH2):c.1760G>C (p.Gly587Ala)]

NM_000251.3(MSH2):c.1760G>C (p.Gly587Ala)

Gene:
MSH2:mutS homolog 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_000251.3(MSH2):c.1760G>C (p.Gly587Ala)
HGVS:
  • NC_000002.12:g.47475025G>C
  • NG_007110.2:g.76902G>C
  • NM_000251.3:c.1760G>CMANE SELECT
  • NM_001258281.1:c.1562G>C
  • NM_001406631.1:c.1760G>C
  • NM_001406632.1:c.1760G>C
  • NM_001406633.1:c.1760G>C
  • NM_001406634.1:c.1760G>C
  • NM_001406635.1:c.1760G>C
  • NM_001406636.1:c.1727G>C
  • NM_001406637.1:c.1760G>C
  • NM_001406638.1:c.1799G>C
  • NM_001406639.1:c.1760G>C
  • NM_001406640.1:c.1760G>C
  • NM_001406641.1:c.1760G>C
  • NM_001406642.1:c.1760G>C
  • NM_001406643.1:c.1760G>C
  • NM_001406644.1:c.1760G>C
  • NM_001406645.1:c.1760G>C
  • NM_001406646.1:c.1760G>C
  • NM_001406647.1:c.1610G>C
  • NM_001406648.1:c.1760G>C
  • NM_001406649.1:c.1610G>C
  • NM_001406650.1:c.1610G>C
  • NM_001406651.1:c.1610G>C
  • NM_001406652.1:c.1610G>C
  • NM_001406653.1:c.1700G>C
  • NM_001406654.1:c.1340G>C
  • NM_001406655.1:c.1760G>C
  • NM_001406656.1:c.863G>C
  • NM_001406657.1:c.1662G>C
  • NM_001406658.1:c.404G>C
  • NM_001406659.1:c.404G>C
  • NM_001406660.1:c.404G>C
  • NM_001406661.1:c.404G>C
  • NM_001406662.1:c.404G>C
  • NM_001406669.1:c.404G>C
  • NM_001406674.1:c.1760G>C
  • NP_000242.1:p.Gly587Ala
  • NP_000242.1:p.Gly587Ala
  • NP_001245210.1:p.Gly521Ala
  • NP_001393560.1:p.Gly587Ala
  • NP_001393561.1:p.Gly587Ala
  • NP_001393562.1:p.Gly587Ala
  • NP_001393563.1:p.Gly587Ala
  • NP_001393564.1:p.Gly587Ala
  • NP_001393565.1:p.Gly576Ala
  • NP_001393566.1:p.Gly587Ala
  • NP_001393567.1:p.Gly600Ala
  • NP_001393568.1:p.Gly587Ala
  • NP_001393569.1:p.Gly587Ala
  • NP_001393570.1:p.Gly587Ala
  • NP_001393571.1:p.Gly587Ala
  • NP_001393572.1:p.Gly587Ala
  • NP_001393573.1:p.Gly587Ala
  • NP_001393574.1:p.Gly587Ala
  • NP_001393575.1:p.Gly587Ala
  • NP_001393576.1:p.Gly537Ala
  • NP_001393577.1:p.Gly587Ala
  • NP_001393578.1:p.Gly537Ala
  • NP_001393579.1:p.Gly537Ala
  • NP_001393580.1:p.Gly537Ala
  • NP_001393581.1:p.Gly537Ala
  • NP_001393582.1:p.Gly567Ala
  • NP_001393583.1:p.Gly447Ala
  • NP_001393584.1:p.Gly587Ala
  • NP_001393585.1:p.Gly288Ala
  • NP_001393586.1:p.Arg554Ser
  • NP_001393587.1:p.Gly135Ala
  • NP_001393588.1:p.Gly135Ala
  • NP_001393589.1:p.Gly135Ala
  • NP_001393590.1:p.Gly135Ala
  • NP_001393591.1:p.Gly135Ala
  • NP_001393598.1:p.Gly135Ala
  • NP_001393603.1:p.Gly587Ala
  • LRG_218t1:c.1760G>C
  • LRG_218:g.76902G>C
  • LRG_218p1:p.Gly587Ala
  • NC_000002.11:g.47702164G>C
  • NM_000251.1:c.1760G>C
  • NM_000251.2:c.1760G>C
  • NR_176230.1:n.1796G>C
  • NR_176231.1:n.1796G>C
  • NR_176232.1:n.1796G>C
  • NR_176233.1:n.1638G>C
  • NR_176234.1:n.1796G>C
  • NR_176235.1:n.1796G>C
  • NR_176236.1:n.1796G>C
  • NR_176237.1:n.1796G>C
  • NR_176238.1:n.1929G>C
  • NR_176239.1:n.1796G>C
  • NR_176240.1:n.1796G>C
  • NR_176241.1:n.1796G>C
  • NR_176242.1:n.1796G>C
  • NR_176243.1:n.1646G>C
  • NR_176244.1:n.1796G>C
  • NR_176245.1:n.1796G>C
  • NR_176246.1:n.1796G>C
  • NR_176247.1:n.1796G>C
  • NR_176248.1:n.1796G>C
  • NR_176249.1:n.2026G>C
  • NR_176250.1:n.1536G>C
Protein change:
G135A
Molecular consequence:
  • NM_000251.3:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001258281.1:c.1562G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406631.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406632.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406633.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406634.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406635.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406636.1:c.1727G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406637.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406638.1:c.1799G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406639.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406640.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406641.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406642.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406643.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406644.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406645.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406646.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406647.1:c.1610G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406648.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406649.1:c.1610G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406650.1:c.1610G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406651.1:c.1610G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406652.1:c.1610G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406653.1:c.1700G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406654.1:c.1340G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406655.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406656.1:c.863G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406657.1:c.1662G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406658.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406659.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406660.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406661.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406662.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406669.1:c.404G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406674.1:c.1760G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002711732Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)		Uncertain significance
(May 23, 2022) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Massively parallel functional testing of MSH2 missense variants conferring Lynch syndrome risk.

Jia X, Burugula BB, Chen V, Lemons RM, Jayakody S, Maksutova M, Kitzman JO.

Am J Hum Genet. 2021 Jan 7;108(1):163-175. doi: 10.1016/j.ajhg.2020.12.003. Epub 2020 Dec 23.

PubMed [citation]
PMID:
33357406
PMCID:
PMC7820803

Details of each submission

From Ambry Genetics, SCV002711732.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.G587A variant (also known as c.1760G>C) is located in coding exon 12 of the MSH2 gene. The glycine at codon 587 is replaced by alanine, an amino acid with similar properties. In a massively parallel cell-based functional assay testing susceptibility to a DNA damaging agent, 6-thioguanine (6-TG), this variant was reported to be functionally neutral (Jia X et al. Am J Hum Genet, 2021 01;108:163-175). This change occurs in the first base pair of coding exon 12. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024